Projects

CBIT facilitates the development of a diverse range of biomedical and healthcare technologies, including medical devices, diagnostics, drug delivery systems, software and mobile phone apps, and processes. Below is a sampling of a few innovative projects CBIT has supported and their stories.

If you wish to join a project, please complete this form detailing your interests, background, and skills, and we can help connect you.

If you have a project idea for which you'd like resources and/or support (mentorship, business, technical development, funding, etc.), please click the "Submit a Project" link on the left and CBIT will be in touch with you about how to move forward.

Spring Health is a tool that leverages Artificial Intelligence (AI) to select suitable treatments for depression, began in the psychiatry department at Yale University. Their proprietary technology was developed by Yale data scientists and psychiatrists, and their research has been published in leading medical journals and recognized by the American Psychiatric Association and National Quality Forum. Early in the team’s foundation, April Koh and Adam Chekroud leveraged BioScience Pipeline funding to establish pilot agreements and create a prototype for clinical evaluation. Spring Health is now working with major insurance companies and closed a $6M round in the summer of 2018.

For more information: https://www.springhealth.com/

StraDEFY, a nanoparticle-based sunscreen and therapeutic platform, was founded by Dr. Mark Saltzman and Dr. Michael Girardi. StraDEFY used BioScience Pipeline funding to prepare for a pilot clinical trial and also received follow-on funding of $100,000 through a Yale Blavatnik award. Actively supported by Yale resources, including Yale Center for Biomedical Innovation and Technology (CBIT), the company is currently engaged in licensing and investor discussions.

Pure Marrow, developed a system for improved bone marrow and stem cell harvesting, was founded by Dr. Elliott Brown who approached CBIT early in the technology’s development. Pure Marrow was awarded BioScience Pipeline funding to create a prototype and conduct preclinical validation. The team was sponsored by the Yale Center for Biomedical Innovation and Technology (CBIT) to attend the Commercialization Readiness Assessment and Accelerator for Solutions in Healthcare (CRAASH) course and received follow-on funding of $100,000 through a Yale Blavatnik award. With continuing support from CBIT and other Yale resources, the company is currently engaged in licensing and investor discussions.

For more information: https://www.puremarrow.com/

MindNest Health provides Digital Parent Training for parents who have children with behavioral health needs such as ADHD, tantrums/disruptive behaviors, anxiety, depression and autism spectrum disorder. The American Academy of Pediatrics identifies parent behavior training as a first line intervention for ADHD and disruptive behaviors in young children. Unfortunately, the majority of families do not have access to parent behavior training and they either receive no treatment at all or must use second-line treatments, such as medication. Dr. David Grodberg founded MindNest Health to provide parents and caregivers with immediate access evidence-based and scalable parent behavior training with coaching support and facilitated referral to a provider when necessary. Such a digital tool can serve as the entrance to the large behavioral health systems for parents who have children with behavioral health needs.

For more information: https://www.mindnesthealth.com/